Revenue
13.8 million uref_314605034
2026 · uref_314605034
Exact inputs and evidence
- Revenue: 13831904 uref_314605034 Source
Annual consolidated revenue for 2026: about uref_314605034 13.83M, using the latest reported figures. The previous period, 2025, was about uref_314605034 14.78M.
13.8 million uref_314605034
2026 · uref_314605034
-149.66%
2026 · %
-12.8 million uref_314605034
2026 · uref_314605034
-12.8 million uref_314605034
2026 · uref_314605034
200000 uref_314605034
1655583530 shares
278.70% · 1.22 billion shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-07-23.
Financial data available through: 2026-03-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
uref_314605034 14.78 million
–
Current period
uref_314605034 13.83 million
–
13831904 − 14777798 = -945894 uref_314605034
14777798 uref_314605034 · 2024-04-01 – 2025-03-31
Inspect prior input Prior source13831904 uref_314605034 · 2025-04-01 – 2026-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−uref_314605034 134.98 million
–
Current period
−uref_314605034 18.67 million
–
-18671610 − -134977369 = 116305759 uref_314605034
-134977369 uref_314605034 · 2024-04-01 – 2025-03-31
Inspect prior input Prior source-18671610 uref_314605034 · 2025-04-01 – 2026-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
uref_314605034 1.18 million
–
Current period
−uref_314605034 12.8 million
–
-12800000 − 1177163 = -13977163 uref_314605034
1177163 uref_314605034 · 2024-04-01 – 2025-03-31
Inspect prior input Prior source-12800000 uref_314605034 · 2025-04-01 – 2026-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
uref_314605034 154,460
–
Current period
uref_314605034 1,638
–
1638 − 154460 = -152822 uref_314605034
154460 uref_314605034 · 2024-04-01 – 2025-03-31
Inspect prior input Prior source1638 uref_314605034 · 2025-04-01 – 2026-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2024 2023-04-01 – 2024-03-31 | 2414338 | 11052378 Derived | -8638040 | 820744 Derived | -9458784 | Unavailable | Source
|
| 2025 2024-04-01 – 2025-03-31 | 14777798 | 181082150 Derived | -166304352 | -31326983 Derived | -134977369 | 1022703 Derived | Source
|
| 2026 2025-04-01 – 2026-03-31 | 13831904 | 34532236 Derived | -20700332 | -2028722 Derived | -18671610 | -12801638 Derived | Source
|
Amounts are exact, in uref_314605034.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(uref_314605034) | Source evidence |
|---|---|---|---|
| 2024 | Revenue | 2414338 |
|
| 2025 | Revenue | 14777798 |
|
| 2026 | Revenue | 13831904 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024 | Year over year | No prior comparable period |
|
| 2025 | Year over year | 512.1% |
|
| 2026 | Year over year | -6.4% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024 | Operating margin | -357.8% |
|
| 2025 | Operating margin | -1,125.4% |
|
| 2026 | Operating margin | -149.7% |
|
| 2024 | Net margin | -391.8% |
|
| 2025 | Net margin | -913.4% |
|
| 2026 | Net margin | -135% |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | 6.9% |
|
| 2026 | Free cash flow margin | -92.6% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(uref_314605034) | Source evidence |
|---|---|---|---|
| 2024 | Operating cash flow | 1351240 |
|
| 2025 | Operating cash flow | 1177163 |
|
| 2026 | Operating cash flow | -12800000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(uref_314605034) | Source evidence |
|---|---|---|---|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | 1022703 |
|
| 2026 | Free cash flow | -12801638 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024-03-31 | Liabilities / assets | Not reported | No source recorded |
| 2025 | Liabilities / assets | 7.4% |
|
| 2026 | Liabilities / assets | 4.6% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2024-03-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2025 | Current assets / current liabilities | 14.2× |
|
| 2026 | Current assets / current liabilities | 21.77× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2024 2023-04-01 – 2024-03-31 | −uref_314605034 9.46 million Exact valueExact value: -9458784 uref_314605034 Share or citeThe citation records this snapshot. The page link may show a newer release later. | uref_314605034 1.35 million Exact valueExact value: 1351240 uref_314605034 Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-04-01 – 2025-03-31 | −uref_314605034 134.98 million Exact valueExact value: -134977369 uref_314605034 Share or citeThe citation records this snapshot. The page link may show a newer release later. | uref_314605034 1.18 million Exact valueExact value: 1177163 uref_314605034 Share or citeThe citation records this snapshot. The page link may show a newer release later. | uref_314605034 154,460 Exact valueExact value: 154460 uref_314605034 Share or citeThe citation records this snapshot. The page link may show a newer release later. | uref_314605034 1.02 million Calculation and evidence1177163 − 154460 uref_314605034 Exact free cash flow: 1022703 uref_314605034
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2026 2025-04-01 – 2026-03-31 | −uref_314605034 18.67 million Exact valueExact value: -18671610 uref_314605034 Share or citeThe citation records this snapshot. The page link may show a newer release later. | −uref_314605034 12.8 million Exact valueExact value: -12800000 uref_314605034 Share or citeThe citation records this snapshot. The page link may show a newer release later. | uref_314605034 1,638 Exact valueExact value: 1638 uref_314605034 Share or citeThe citation records this snapshot. The page link may show a newer release later. | −uref_314605034 12.8 million Calculation and evidence-12800000 − 1638 uref_314605034 Exact free cash flow: -12801638 uref_314605034
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
109 filings · 1,300 latest values · 1,300 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001702318, 1702318, AHG, edgar:1702318
Also known as Akso Health Group, Hexindai Inc., Xiaobai Maimai Inc.